Membranous Nephropathy
📧 Sign up to get email alerts when something new happens for Membranous Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy [Phase 2]
A Phase 2 randomized, open-label, multicenter trial evaluating SHR-2173 for primary membranous nephropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study) [Phase 3]
Phase 3 Blossom Study comparing Obinutuzumab against cyclophosphamide plus glucocorticoids for primary membranous nephropathy is currently r…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Atacicept in Multiple Glomerular Diseases [Phase 2]
Phase 2 clinical trial evaluating atacicept in multiple glomerular diseases is currently recruiting, including primary membranous nephropath…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study [Phase 2, Phase 3]
A pilot Phase 2/3 clinical trial is evaluating obinutuzumab for membranous nephropathy with PLA2R antibody decreases, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy [Phase 1]
Phase 1 clinical trial evaluating safety and efficacy of CD19 CAR-T cell therapy for refractory membranous nephropathy is currently recruiti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
This clinical trial update describes an interview study of adult and pediatric patients with swelling due to nephrotic syndrome and of paren…
-
CLINICAL_TRIALS withdrawal · 2025-11-28Clinical Trial Update: REmission in Membranous Nephropathy International Trial (REMIT) [Phase 3]
Phase 3 REMIT trial for primary membranous nephropathy has been withdrawn.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy [Phase 2]
A Phase II study evaluating Zuberitamab injection in patients with primary membranous nephropathy is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis [Phase 2]
Phase 2 trial evaluating HLX79 in combination with Rituximab versus placebo for active glomerulonephritis, including membranous nephropathy …
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Phase Ib/ Ⅱ Clinical Study of MIL62 in Primary Membranous Nephropathy [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating MIL62 in primary membranous nephropathy has completed.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Study of YK012 in Primary Membranous Nephropathy [Phase 1]
A Phase 1 clinical trial evaluating YK012 in primary membranous nephropathy is currently recruiting. The sponsor is Excyte Biopharma Ltd.
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases [Phase 1, Phase 2]
An open-label Phase 1/2 study evaluating povetacicept in autoantibody-associated glomerular diseases is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. [EARLY_Phase 1]
Phase 1 study evaluating anti-CD19/BCMA universal CAR-T cell therapy RD06-05 in autoimmune diseases; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX) [Phase 3]
A Phase 3 clinical trial called iRITUX is testing AI-guided, personalized rituximab treatment for membranous nephropathy. The study is curre…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy [Phase 3]
Phase 3 trial of mycophenolate mofetil in progressive idiopathic membranous nephropathy has completed and results have been posted.
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: A Real World Study About PMN
This clinical trial update shows a real-world study on Primary Membranous Nephropathy that is currently recruiting, sponsored by Wei Chen.
-
CLINICAL_TRIALS other · 2025-08-20Clinical Trial Update: A Phase Ⅲ Clinical Study of MIL62 in Primary Membranous Nephropathy [Phase 3]
A Phase 3 clinical trial evaluating MIL62 for primary membranous nephropathy is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy [Phase 2]
A Phase 2 clinical trial is planned to evaluate dapagliflozin for regulating immunological activity in membranous nephropathy; the study is …
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy [Phase 2]
A Phase 2 clinical trial evaluating JMT601 in adults with primary membranous nephropathy, sponsored by Shanghai JMT-Bio Inc., is currently n…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases [Phase 1]
Phase 1 clinical trial evaluating a BCMA/CD19 dual-targeted CAR-T cell therapy for autoimmune kidney diseases, currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
A clinical trial update from Assistance Publique - Hôpitaux de Paris describes a study on epithelial dysmetabolism and renal fibrosis in ANC…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001 [Phase 1]
A Phase 1 study is evaluating EVER001 for primary membranous nephropathy, focusing on efficacy, safety, pharmacokinetics and pharmacodynamic…
-
CLINICAL_TRIALS other · 2025-05-09Clinical Trial Update: Obinutuzumab in Primary MN [Phase 2]
A Phase 2 clinical trial of obinutuzumab for primary membranous nephropathy is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Nephrotic Syndrome Study Network
Clinical trial update from the Nephrotic Syndrome Study Network indicating that the study is currently recruiting for conditions including M…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Optimization of a Decision Formula for Optimal Timing of Immunosuppressive Therapy Initiation in Primary Membranous Nephropathy: A Multicenter Retrospective Cohort Study
A multicenter retrospective cohort study aiming to optimize a decision formula for the timing of initiating immunosuppressive therapy in pat…